Laurent Boissel

Company: ImmunityBio Inc.

Job title: Director - Research & Development Cellular

Seminars:

Addressing Efficacy, Safety & Allo- Rejection with Engineered NK Products in the Clinic 12:30 pm

Driving clinical efficacy and cell fitness and cytokine expansion of NK cells in combination with modified antibodies and CAR engineering Discussing the clinical application of combination immunotherapy Integrating safety switches and HLA neutrality to ensure safety of allogeneic therapy Contrasting the clinical benefit of engineered cells from different sourcesRead more

day: Day One Track B AM